Trophoblast Cell Surface Antigen 2 (Trop-2) Protein is Highly Expressed in Salivary Gland Carcinomas and Represents a Potential Therapeutic Target

By P. Wolber, L. Nachtsheim, F. Hoffmann, J. Klussmann, M. Meyer, F. von Eggeling, O. Guntinas-Lichius, Alexander Quaas, C. Arolt. 2021

Subfields: Oncology, Pathology and Forensic Medicine

Citations in the corpus

• A Phase II study of SHR-A1921, a TROP2-targeted antibody–drug conjugate, in patients with recurrent or metastatic salivary gland carcinoma (2026, unknown): “While TROP-2 overexpression is prognostic in several malignancies 11 , its predictive role in SGC remains unproven 10 .”